Atrial Fibrillation Screening in Nursing Homes
Screening for Atrial Fibrillation in High-Risk Nursing Home Residents
1 other identifier
observational
245
1 country
1
Brief Summary
This study was designed to screen high risk patients in nursing homes for atrial fibrillation with intermittent electrocardiogram (ECG) recordings using a portable, smartphone-based, mobile ECG recording device (Kardia Mobile, AliveCor, Inc.). The investigators hypothesized that screening patients with 2 or more risk factors for atrial fibrillation would yield a higher incidence of atrial fibrillation compared to prior studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 14, 2019
CompletedFirst Posted
Study publicly available on registry
March 1, 2019
CompletedMarch 4, 2019
February 1, 2019
9 months
February 14, 2019
February 28, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
atrial fibrillation
number of participants with atrial fibrillation on any of four rhythm recordings
30 days
Interventions
Recording of ECG rhythm on a portable monitor (Kardia Mobile)
Eligibility Criteria
nursing home residents
You may qualify if:
- Nursing home residents with ≥2 of the following risk factors for atrial fibrillation:
- age ≥75 years
- female sex
- obstructive sleep apnea
- peripheral vascular disease
- diabetes mellitus
- obesity (body mass index \[BMI\] \>30 kg/m2)
- hypertension
- congestive heart failure
You may not qualify if:
- prior diagnosis of AF
- continuous rhythm monitoring over the past year
- pacemaker or implantable cardioverter defibrillator in situ
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CTRC
Buffalo, New York, 14203, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne B Curtis, MD
University at Buffalo
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- SUNY Distinguished Professor
Study Record Dates
First Submitted
February 14, 2019
First Posted
March 1, 2019
Study Start
February 1, 2018
Primary Completion
November 1, 2018
Study Completion
November 1, 2018
Last Updated
March 4, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share